Nanomicelles for GLUT1-targeting hepatocellular carcinoma therapy based on NADPH depletion

Nanomicelles for GLUT1-targeting hepatocellular carcinoma therapy based on NADPH depletion

AbstractHepatocellular carcinoma (HCC) is a malignant tumor leading cancer-associated high mortality worldwide. Unfortunately, the most commonly used drug therapeutics not only lack of target ability and efficiency, but also exhibit severe systemic toxicity to normal tissues. Thus, effective and tar...

Full description

Bibliographic Details
Main Authors: Congyi Zhang, Zehui Liu, Feng Wang, Bin Zhang, Xirui Zhang, Peiwen Guo, Tianwei Li, Sheng Tai, Changmei Zhang
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Drug Delivery
Subjects:
Hepatocellular carcinoma
nanomicelles
GLUT1-targeting
NADPH depletion
Online Access:https://www.tandfonline.com/doi/10.1080/10717544.2022.2162160

Internet

https://www.tandfonline.com/doi/10.1080/10717544.2022.2162160

Similar Items